1r5i: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1r5i.gif|left|200px]]
{{Seed}}
[[Image:1r5i.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1r5i|  PDB=1r5i  |  SCENE=  }}  
{{STRUCTURE_1r5i|  PDB=1r5i  |  SCENE=  }}  


'''Crystal structure of the MAM-MHC complex'''
===Crystal structure of the MAM-MHC complex===




==Overview==
<!--  
Mycoplasma arthritidis-derived mitogen (MAM) is a superantigen that can activate large fractions of T cells bearing particular TCR Vbeta elements. Here we report the crystal structure of MAM complexed with a major histocompatibility complex (MHC) antigen, HLA-DR1, loaded with haemagglutinin peptide 306-318 (HA). The structure reveals that MAM has a novel fold composed of two alpha-helical domains. This fold is entirely different from that of the pyrogenic superantigens, consisting of a beta-grasped motif and a beta barrel. In the complex, the N-terminal domain of MAM binds orthogonally to the MHC alpha1 domain and the bound HA peptide, and to a lesser extent to the MHC beta1 domain. Two MAM molecules form an asymmetric dimer and cross-link two MHC antigens to form a plausible, dimerized MAM-MHC complex. These data provide the first crystallographic evidence that superantigens can dimerize MHC molecules. Based on our structure, a model of the TCR2MAM2MHC2 complex is proposed.
The line below this paragraph, {{ABSTRACT_PUBMED_14962388}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 14962388 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_14962388}}


==About this Structure==
==About this Structure==
Line 33: Line 37:
[[Category: Mhc]]
[[Category: Mhc]]
[[Category: Superantigen]]
[[Category: Superantigen]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 07:06:23 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 17:05:39 2008''